Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R P Harbottle

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Gene Therapy|August 27, 2010
Non-viral S/MAR vectors replicate episomally in vivo when provided with a selective advantageS P Wong, O Argyros, C Coutelle, et al.
FEBS Letters|November 26, 1999
Targeted gene delivery into alpha9beta1-integrin-displaying cells by a synthetic peptideH Schneider, R P Harbottle, Y Yokosaki, et al.
Gene|November 21, 1996
A recombinant, arginine-glycine-aspartic acid (RGD) motif from foot-and-mouth disease virus binds mammalian cells through vitronectin and, to a lower extent, fibronectin receptorsA Villaverde, J X Feliu, R P Harbottle, et al.
FEBS Letters|July 14, 1998
A novel peptide, PLAEIDGIELTY, for the targeting of alpha9beta1-integrinsH Schneider, R P Harbottle, Y Yokosaki, et al.
Biotechnology and Bioengineering|April 1, 1999
A cell adhesion peptide from foot-and-mouth disease virus can direct cell targeted delivery of a functional enzymeA Villaverde, J X Feliu, A Arís, et al.
Gene Therapy|October 1, 1995
Gene delivery and expression mediated by an integrin-binding peptideS L Hart, R P Harbottle, R Cooper, et al.
FEBS Letters|February 13, 2001
A novel peptide, THALWHT, for the targeting of human airway epitheliaP J Jost, R P Harbottle, A Knight, et al.
The Journal of Biological Chemistry|April 29, 1994
Cell binding and internalization by filamentous phage displaying a cyclic Arg-Gly-Asp-containing peptideS L Hart, A M Knight, R P Harbottle, et al.
Gene Therapy|July 18, 2008
Persistent episomal transgene expression in liver following delivery of a scaffold/matrix attachment region containing non-viral vectorO Argyros, S P Wong, M Niceta, et al.
Human Gene Therapy|June 2, 1998
An RGD-oligolysine peptide: a prototype construct for integrin-mediated gene deliveryR P Harbottle, R G Cooper, S L Hart, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Gene Therapy|August 27, 2010
Non-viral S/MAR vectors replicate episomally in vivo when provided with a selective advantageS P Wong, O Argyros, C Coutelle, et al.
FEBS Letters|November 26, 1999
Targeted gene delivery into alpha9beta1-integrin-displaying cells by a synthetic peptideH Schneider, R P Harbottle, Y Yokosaki, et al.
Gene|November 21, 1996
A recombinant, arginine-glycine-aspartic acid (RGD) motif from foot-and-mouth disease virus binds mammalian cells through vitronectin and, to a lower extent, fibronectin receptorsA Villaverde, J X Feliu, R P Harbottle, et al.
FEBS Letters|July 14, 1998
A novel peptide, PLAEIDGIELTY, for the targeting of alpha9beta1-integrinsH Schneider, R P Harbottle, Y Yokosaki, et al.
Biotechnology and Bioengineering|April 1, 1999
A cell adhesion peptide from foot-and-mouth disease virus can direct cell targeted delivery of a functional enzymeA Villaverde, J X Feliu, A Arís, et al.
Gene Therapy|October 1, 1995
Gene delivery and expression mediated by an integrin-binding peptideS L Hart, R P Harbottle, R Cooper, et al.
FEBS Letters|February 13, 2001
A novel peptide, THALWHT, for the targeting of human airway epitheliaP J Jost, R P Harbottle, A Knight, et al.
The Journal of Biological Chemistry|April 29, 1994
Cell binding and internalization by filamentous phage displaying a cyclic Arg-Gly-Asp-containing peptideS L Hart, A M Knight, R P Harbottle, et al.
Gene Therapy|July 18, 2008
Persistent episomal transgene expression in liver following delivery of a scaffold/matrix attachment region containing non-viral vectorO Argyros, S P Wong, M Niceta, et al.
Human Gene Therapy|June 2, 1998
An RGD-oligolysine peptide: a prototype construct for integrin-mediated gene deliveryR P Harbottle, R G Cooper, S L Hart, et al.
Pageof 2